Phospholipase C . See

G proteins are divided into several types, depending on their effects. Stimulatory G proteins (Cs) are widespread. They activate adenylate cyclases (see below) or influence ion channels. Inhibitory G proteins (Cj) inhibit adenylate cyclase. G proteins in the Gq family activate another effector enzyme—phospholipase c (see p. 386). 

Consistent with the sequence similarities between the ORLl and opioid receptors, activation of the ORLl receptor triggers the same signal transduction mechanisms as used by the opioid receptors. Thus activation of ORLl receptors inhibits both forskolin-stimulated adenylyl (yclase and currents and activates several other effectors, including inward rectifying channels, protein kinase C, mitogen-activated protein kinase (MAP kinase) and phospholipase C (see Ref 89 for a review). 

The a-1 receptors bind certain agonists as epinephrine in the liver and muscle in this case, the a subunit of the G protein with GTP interacts to increase phospholipase C (see Fig. 16.3). 

Hentze H-P, Co CC, McKelvey CA, Kaler EW (2003) Templating Vesicles, Microemulsions and Lyotropic Mesophases by Organic Polymerization Processes. 226 197-223 Hergenrother PJ, Martin SE (2000) Phosphatidylcholine-Preferring Phospholipase C from B. cereus. Eunction, Structure, and Mechanism. 2ii 131 -167 Hermann C, see Kuhlmann J (2000) 211 61-116... 

The a subunits and the Py complex have actions independent of those on adenylyl cyclase (see Figure 43-4 and Table 43-3). Some forms of tt stimulate channels and inhibit Ca channels, and some ttj molecules have the opposite effects. Members of the G, family activate the phospholipase C group of enzymes. The py complexes have been associated with channel stimulation and phospholipase C activation. G proteins are involved in many important biologic processes in addition to hormone action. Notable examples include olfaction (oColf) <1 vision (aj. Some examples are listed in Table 43-3. GPCRs are implicated in a number of diseases and are major targets for pharmaceutical agents. 

The mechanisms involved in platelet activation are discussed in Chapter 51 (see Figure 51-8). The process involves interaction of the stimulus (eg, thrombin) with a receptor, activation of G proteins, stimulation of phospholipase C, and hberation from phosphatidylinositol... 

Muscarinic receptor activation causes inhibition of adenylyl cyclase, stimulation of phospholipase C and regulation of ion channels. Many types of neuron and effector cell respond to muscarinic receptor stimulation. Despite the diversity of responses that ensue, the initial event that follows ligand binding to the muscarinic receptor is, in all cases, the interaction of the receptor with a G protein. Depending on the nature of the G protein and the available effectors, the receptor-G-protein interaction can initiate any of several early biochemical events. Common responses elicited by muscarinic receptor occupation are inhibition of adenylyl cyclase, stimulation of phos-phoinositide hydrolysis and regulation of potassium or other ion channels [47] (Fig. 11-10). The particular receptor subtypes eliciting those responses are discussed below. (See also Chs 20 and 21.)... 

The family of heterotrimeric G proteins is involved in transmembrane signaling in the nervous system, with certain exceptions. The exceptions are instances of synaptic transmission mediated via receptors that contain intrinsic enzymatic activity, such as tyrosine kinase or guanylyl cyclase, or via receptors that form ion channels (see Ch. 10). Heterotrimeric G proteins were first identified, named and characterized by Alfred Gilman, Martin Rodbell and others close to 20 years ago. They consist of three distinct subunits, a, (3 and y. These proteins couple the activation of diverse types of plasmalemma receptor to a variety of intracellular processes. In fact, most types of neurotransmitter and peptide hormone receptor, as well as many cytokine and chemokine receptors, fall into a superfamily of structurally related molecules, termed G-protein-coupled receptors. These receptors are named for the role of G proteins in mediating the varied biological effects of the receptors (see Ch. 10). Consequently, numerous effector proteins are influenced by these heterotrimeric G proteins ion channels adenylyl cyclase phosphodiesterase (PDE) phosphoinositide-specific phospholipase C (PI-PLC), which catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) and phospholipase A2 (PLA2), which catalyzes the hydrolysis of membrane phospholipids to yield arachidonic acid. In addition, these G proteins have been implicated in... 

Capacitative Ca2+ entry is the predominant mode of regulated Ca2+ entry in nonexcitable cells but it also occurs in a number of excitable cell types. This pathway of Ca2+ entry is usually associated with the activation of phospholipase C, which mediates the formation of IP3 (see Ch. 20). Intracellular application of IP3 mimics the ability of hormones and neurotransmitters to activate calcium ion entry, and activation of calcium ion entry by hormones and neurotransmitters can be blocked by intracellular application of low-molecular-weight heparin, which potently antagonizes IP3 binding to its receptor. There is considerable evidence for the presence of an IP3 receptor in the plasma membrane of some cells types. 1(1,3,4,5)P4, a product of IP3 phosphorylation, has been shown in some cells to augment this action of IP3 in activating PM calcium ion entry, but in others IP3 alone is clearly sufficient. 

This can be illustrated by known interactions between the cAMP and Ca2+ pathways. A first messenger that initially activates the cAMP pathway would be expected to exert secondary effects on the Ca2+ pathway at many levels via phosphorylation by PKA. First, Ca2+ channels and the inositol trisphosphate (IP3) receptor will be phosphorylated by PKA to modulate intracellular concentrations of Ca2+. Second, phospholipase C (PLC) is a substrate for PKA, and its phosphorylation modulates intracellular calcium concentrations, via the generation of IP3) as well as the activity of PKC, via the generation of DAG, and several types of CAMK. Similarly, the Ca2+ pathway exerts potent effects on the cAMP pathway, for example, by activating or inhibiting the various forms of adenylyl cyclase expressed in mammalian tissues (see Ch. 21). 

---